Task: Answer the multiple-choice question.
Query: Which drug exhibits a 3.182\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] O=C(N1CCOCC1)C12CCC3CC(CC(C3)C1)C2
[b] CCNC(=O)CC1SC(=Nc2cccc(Cl)c2C)N(C)C1=O
[c] COc1ccc(NC(=O)c2ccc3ncsc3c2)c2ccccc12
Answer: b. CCNC(=O)CC1SC(=Nc2cccc(Cl)c2C)N(C)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCNC(=O)CC1SC(=Nc2cccc(Cl)c2C)N(C)C1=O
CCNC(=O)CC1SC(=Nc2cccc(Cl)c2C)N(C)C1=O
2-[2-(3-chloro-2-methylphenyl)imino-3-methyl-4-oxo-1,3-thiazolidin-5-yl]-N-ethylacetamide